Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0001209191-14-048710

Options or other derivatives

  • Chief Financial Officer acquired 67,642 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Tulipano Stephen J Chief Financial Officer 2014-07-21 Grant or award · Employee Stock Option (Right to Buy) +67,642 67,642 D
Loading xslF345X03/doc4.xml…